Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxy lic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist
Access Status
Fulltext not available
Authors
Kumar Srivastava, B.
Soni, R.
Patel, J.
Jha, S.
Shedage, S.
Gandhi, Neha
Sairam, K.
Pawar, V.
Sadhwani, N.
Mitra, P.
Jain, M.
Patel, P.
Date
2008Type
Journal Article
Metadata
Show full item recordCitation
Kumar Srivastava, B. and Soni, R. and Patel, J. and Jha, S. and Shedage, S. and Gandhi, N. and Sairam, K. et al. 2008. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxy lic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 18 (14): pp. 3882-3886.
Source Title
Bioorganic & Medicinal Chemistry Letters
ISSN
School
School of Biomedical Sciences
Collection
Abstract
Facile synthesis of biaryl pyrazole sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxy lic acid piperidin-1-ylamide (SR141716, 1) and an investigation of the effect of replacement of the -CO group in the compound 1 by the -SO2 group in the aminopiperidine region is reported. Primary ex-vivo pharmacological testing and in vitro screening of sulfonamide derivative 2 showed the loss of CB1 receptor antagonism. © 2008 Elsevier Ltd. All rights reserved.